← Back to All Filings

Natera Officer Michael Brophy Files Form 144 for $484K Share Sale

Low SignificanceOctober 28, 2026 at 6:07:28 PM EDT

Natera, Inc.

$NTRA144CIK: 0001604821

Subscribe to track NTRA

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Proposed sale of 1,178 common shares ($483,945.96) by Officer Michael Burkes Brophy under Rule 144. Shares were acquired via RSU vesting on 10/26/2026 and sold pursuant to a Rule 10b5-1 plan adopted on 09/10/2025.

Comprehensive Analysis

Executive Summary

On October 28, 2026, Michael Burkes Brophy, an Officer of Natera, Inc. (NASDAQ: NTRA), filed a Form 144 notice of proposed sale covering 1,178 shares of common stock with an aggregate market value of approximately $483,946.

Transaction Details

  • Filer: Michael Burkes Brophy (Officer)
  • Number of Shares: 1,178
  • Estimated Aggregate Market Value: $483,945.96 (~$410.82 per share)
  • Acquisition Origin: Shares were acquired on October 26, 2026, through the vesting of Restricted Stock Units (RSUs) granted by the issuer.
  • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  • Trading Plan: The transaction is scheduled pursuant to a Rule 10b5-1 trading plan adopted on September 10, 2025.

Past 3 Months Activity

The filer reported prior sales within the past three months totaling 3,429 shares for aggregate gross proceeds of approximately $992,803, also largely executed under 10b5-1 arrangements.

Market Impact & Significance

This filing carries Low trading significance. The transaction represents a negligible fraction of Natera's 144,144,170 shares outstanding and is executed under a pre-established Rule 10b5-1 plan in connection with recently vested RSUs.

Topics:#NTRA#Natera#Form144#InsiderSelling#Biotech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.